Imaging for the Prediction and/or Detection of Skin Cancer

Back to all technologies
Download as PDF
66271
Recent animal studies have demonstrated that primary tumor formation sites can be discerned before a tumor develops by taking measurements of the hemoglobin and extracellular matrix structures in the skin.

Purdue University researchers have developed a technique (and possible device) to predict where a tumor will form on the skin after exposure to a carcinogen. The current area surveyed can be a few hundred millimeters squared and penetrates two millimeters in depth. In mouse studies, the technique predicted the result of foci with a high statistical accuracy. Applications of this technology include tissue engineering scaffold development, dermatology rejuvenation and diagnosis, diagnostic screening of patients who have undergone laser treatments, toxicology studies testing the response to a drug, and devices for pathologist to use in the operating room to get a better understanding of the margins on a tumor.

Advantages:
-Predicts where a tumor will form on the skin
-Can help surgeons better understand the margins of a tumor
-High statistical accuracy in mouse studies

Potential Applications:
-Medical/Healthcare
-Medical imaging
-Cancer detection
Jun 9, 2015
CIP-Patent
United States
(None)
(None)

Jun 9, 2014
Provisional-Patent
United States
(None)
(None)

Aug 12, 2013
Utility Patent
United States
(None)
(None)

Aug 11, 2012
Provisional-Patent
United States
(None)
(None)
Purdue Office of Technology Commercialization
1801 Newman Road
West Lafayette, IN 47906

Phone: (765) 588-3475
Fax: (765) 463-3486
Email: otcip@prf.org